Melt Spray Congeal Microspheres: A Flexible Oral Multiparticulate Platform for Patients

18 September 2023 09:10 - 09:40

  • Pharmaceutical development pathway integrating patient needs, development considerations and physico-chemical/biopharmaceutical compound profile
  • Integrated CMC platform from developability assessment, formulation design and process optimization leading to a robust commercial dosage form
  • Case studies showcasing how an integrated CMC platform can accelerate timelines

Sheri Shamblin, Director, Pfizer